A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan
Clinical trial NCT04043975 · COMPLETED
Trial details
- NCT number
- NCT04043975
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-19
- Primary completion
- 2024-08-23
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.